JP2025505609A5 - - Google Patents

Info

Publication number
JP2025505609A5
JP2025505609A5 JP2024546123A JP2024546123A JP2025505609A5 JP 2025505609 A5 JP2025505609 A5 JP 2025505609A5 JP 2024546123 A JP2024546123 A JP 2024546123A JP 2024546123 A JP2024546123 A JP 2024546123A JP 2025505609 A5 JP2025505609 A5 JP 2025505609A5
Authority
JP
Japan
Application number
JP2024546123A
Other languages
Japanese (ja)
Other versions
JP2025505609A (ja
JPWO2023150291A5 (https=
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2023/012307 external-priority patent/WO2023150291A2/en
Publication of JP2025505609A publication Critical patent/JP2025505609A/ja
Publication of JP2025505609A5 publication Critical patent/JP2025505609A5/ja
Publication of JPWO2023150291A5 publication Critical patent/JPWO2023150291A5/ja
Pending legal-status Critical Current

Links

JP2024546123A 2022-02-04 2023-02-03 複素環式化合物及び使用方法 Pending JP2025505609A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US202263306784P 2022-02-04 2022-02-04
US63/306,784 2022-02-04
US202263376595P 2022-09-21 2022-09-21
US63/376,595 2022-09-21
PCT/US2023/012307 WO2023150291A2 (en) 2022-02-04 2023-02-03 Heterocyclic compounds and methods of use

Publications (3)

Publication Number Publication Date
JP2025505609A JP2025505609A (ja) 2025-02-28
JP2025505609A5 true JP2025505609A5 (https=) 2026-02-19
JPWO2023150291A5 JPWO2023150291A5 (https=) 2026-02-19

Family

ID=87552839

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024546123A Pending JP2025505609A (ja) 2022-02-04 2023-02-03 複素環式化合物及び使用方法

Country Status (14)

Country Link
US (1) US20230348424A1 (https=)
EP (1) EP4472974A4 (https=)
JP (1) JP2025505609A (https=)
KR (1) KR20240155872A (https=)
AU (1) AU2023215383A1 (https=)
CA (1) CA3243353A1 (https=)
CL (1) CL2024002328A1 (https=)
CO (1) CO2024010726A2 (https=)
CR (1) CR20240362A (https=)
IL (1) IL314594A (https=)
MX (1) MX2024009608A (https=)
PE (1) PE20250681A1 (https=)
TW (1) TW202342461A (https=)
WO (1) WO2023150291A2 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3229566A1 (en) * 2021-08-17 2023-02-23 Kanaph Therapeutics Inc. Sos1 inhibitor and use thereof
WO2025163050A1 (en) * 2024-01-31 2025-08-07 Les Laboratoires Servier New amide derivatives, pharmaceutical compositions containing them and their uses as sos1 inhibitors

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW201143768A (en) * 2009-12-15 2011-12-16 Lundbeck & Co As H Pyridone derivatives as NK3 antagonists
WO2016077793A1 (en) * 2014-11-14 2016-05-19 Children's Hospital Medical Center Sos1 inhibitors for cancer treatment
RS64167B1 (sr) * 2017-12-21 2023-05-31 Boehringer Ingelheim Int Benzilamino supstituisani piridopirimidinoni i derivati kao sos1 inhibitori
KR20240013792A (ko) * 2021-05-27 2024-01-30 슈뢰딩거, 인크. 헤테로시클릭 화합물 및 사용 방법

Similar Documents

Publication Publication Date Title
BR102023014872A2 (https=)
BR102023012440A2 (https=)
BR102023010976A2 (https=)
BR102023009641A2 (https=)
BR102023008688A2 (https=)
BR102023007252A2 (https=)
BR102023005164A2 (https=)
BR102023001877A2 (https=)
BR102023000289A2 (https=)
BR102022026909A2 (https=)
BR202022009269U2 (https=)
BR202022005961U2 (https=)
BR202022001779U2 (https=)
BR202022000931U2 (https=)
BY13149U (https=)
BY13157U (https=)
BY13135U (https=)
BY13137U (https=)
CN307049371S (https=)
BY13141U (https=)
BY13142U (https=)
BY13143U (https=)
BY13144U (https=)
BY13145U (https=)
CN307048196S (https=)